Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-6.18%
operating margin TTM
-4.44%
revenue TTM
441.25 Million
revenue per share TTM
4.41$
valuation ratios | |
|---|---|
| pe ratio | -18.32 |
| peg ratio | -0.19 |
| price to book ratio | -212.15 |
| price to sales ratio | 0.87 |
| enterprise value multiple | -28.55 |
| price fair value | -212.15 |
profitability ratios | |
|---|---|
| gross profit margin | 10.79% |
| operating profit margin | -4.44% |
| pretax profit margin | -6.18% |
| net profit margin | -6.18% |
| return on assets | -20.36% |
| return on equity | 209.81% |
| return on capital employed | -31.32% |
liquidity ratios | |
|---|---|
| current ratio | 1.36 |
| quick ratio | 1.15 |
| cash ratio | 0.43 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 20.14 |
| operating cycle | 61.61 |
| days of payables outstanding | 60.68 |
| cash conversion cycle | 0.93 |
| receivables turnover | 8.80 |
| payables turnover | 6.01 |
| inventory turnover | 18.12 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | -0.99 |
| long term debt to capitalization | -2.31 |
| total debt to capitalization | -80.69 |
| interest coverage | -3.42 |
| cash flow to debt ratio | 0.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.00 |
| cash per share | 0.04 |
| operating cash flow per share | 0.00 |
| free cash flow operating cash flow ratio | -10.02 |
| cash flow coverage ratios | 0.01 |
| short term coverage ratios | 0.05 |
| capital expenditure coverage ratio | 0.09 |
Frequently Asked Questions
When was the last time The Oncology Institute, Inc. (NASDAQ:TOI) reported earnings?
The Oncology Institute, Inc. (TOI) published its most recent earnings results on 30-06-2026.
What is The Oncology Institute, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. The Oncology Institute, Inc. (NASDAQ:TOI)'s trailing twelve months ROE is 209.81%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. The Oncology Institute, Inc. (TOI) currently has a ROA of -20.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TOI's net profit margin stand at?
TOI reported a profit margin of -6.18% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TOI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.36 in the most recent quarter. The quick ratio stood at 1.15, with a Debt/Eq ratio of -0.99.